CRSP Crispr Therapeutics AG
Company Analysis
Latest News
🔴 Crispr Therapeutics AG is trading 10.0% down today as strong jobs data triggers growth selloff
Crispr Therapeutics AG is trading at $51.24 (10.0% down) as a stronger-than-expected U.S. jobs report pressures rate-sensitive growth stocks and prompts...
🔴 Crispr Therapeutics AG is trading 4.71% down today amid a broad tech-led selloff and profit-taking
Crispr Therapeutics AG is trading at $54.27 (-4.71%) today, giving back a portion of its June 4 rally during a wider market retreat. • The decline aligns with...
CRSP Surges 12% on CEO's Bullish Conference Talk — But Can a $43 Million Therapy Justify $4.7 Billion in Market Value?
Shares of Crispr Therapeutics vaulted 12.2% to $58.45 on June 4 after CEO Samarth Kulkarni delivered an upbeat fireside chat at the Jefferies Global Healthcare...
🟢 Crispr Therapeutics AG is trading 12.2% up today after CEO highlights strong CASGEVY outlook
Crispr Therapeutics AG is trading 12.2% up at $58.45 after CEO Sam Kulkarni delivered an upbeat presentation at the Jefferies Global Healthcare Conference. •...
🟢 Crispr Therapeutics AG soars 13.2% after CEO highlights promising pipeline at investor conference
Crispr Therapeutics AG is trading up 13.2% today at $58.94 following an optimistic presentation by CEO Sam Kulkarni at the Jefferies Global Healthcare...
🔴 Crispr Therapeutics AG is trading 4% down despite potentially positive FDA guidance for the gene therapy sector
Crispr Therapeutics AG is trading 4% down at $52.01, a move that comes amid mixed signals for the gene-editing sector. While the stock appears to be undergoing...